More than half of CRSwNP patients treated with dupilumab experience olfactory improvement within 28 daysTo the Editor, Olfactory dysfunction is one of the main complaints of patients suffering from Chronic Rhinosinusitis with Nasal Polyps, significantly affecting their quality of life.Dupilumab has proven to effectively enhance olfactory function within six months of treatment (1-3).However, the speed and efficacy of this effect on olfactory function improvement within the initial weeks of treatment has yet to be determined.
No takes yet. Share an insight, caveat, or question.
Otten et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: